RESUMO
Background/Aims@#To analyze the incidence and risk factors of outcomes after liver transplantation (LT) in the Korean population. @*Methods@#This study analyzed data from the liver cohort of Korean Organ Transplantation Registry (KOTRY) who had LT between May 2014 and December 2017. Study measures included the incidence of post-LT outcomes in recipients of living donor LT (LDLT) and deceased donor LT (DDLT). Cox multivariate proportional hazards model was used to determine the potential risk factors predicting the outcomes. @*Results@#A total of 2,563 adult recipients with LT (LDLT, n=1,956; DDLT, n=607) were included, with mean±standard deviation age of 53.9±8.9 years, and 72.2% were male. The post-LT outcomes observed in each LDLT and DDLT recipients were death (4.0% and 14.7%), graft loss (5.0% and 16.1%), rejection (7.0% and 12.0%), renal failure (2.7% and 13.8%), new onset of diabetes (12.5% and 15.4%), and hepatocellular carcinoma (HCC) recurrence (both 6.7%). In both LDLT and DDLT recipients, the most common post-LT complications were renal dysfunction (33.6% and 51.4%), infection (26.7% and 48.4%), and surgical complication (22.5% and 23.9%). Incidence of these outcomes were generally higher among recipients of DDLT than LDLT. Multivariate analysis indicated recipient age and DDLT as significant risk factors associated with death and graft loss. DDLT and ABO incompatible transplant were prognostic factors for rejection, and HCC beyond Milan criteria at pre-transplant was a strong predictor of HCC recurrence. @*Conclusions@#This study is a good indicator of the post-LT prognosis in the Korean population and suggests a significant burden of post-LT complications.
RESUMO
Background/Aims@#To analyze the incidence and risk factors of outcomes after liver transplantation (LT) in the Korean population. @*Methods@#This study analyzed data from the liver cohort of Korean Organ Transplantation Registry (KOTRY) who had LT between May 2014 and December 2017. Study measures included the incidence of post-LT outcomes in recipients of living donor LT (LDLT) and deceased donor LT (DDLT). Cox multivariate proportional hazards model was used to determine the potential risk factors predicting the outcomes. @*Results@#A total of 2,563 adult recipients with LT (LDLT, n=1,956; DDLT, n=607) were included, with mean±standard deviation age of 53.9±8.9 years, and 72.2% were male. The post-LT outcomes observed in each LDLT and DDLT recipients were death (4.0% and 14.7%), graft loss (5.0% and 16.1%), rejection (7.0% and 12.0%), renal failure (2.7% and 13.8%), new onset of diabetes (12.5% and 15.4%), and hepatocellular carcinoma (HCC) recurrence (both 6.7%). In both LDLT and DDLT recipients, the most common post-LT complications were renal dysfunction (33.6% and 51.4%), infection (26.7% and 48.4%), and surgical complication (22.5% and 23.9%). Incidence of these outcomes were generally higher among recipients of DDLT than LDLT. Multivariate analysis indicated recipient age and DDLT as significant risk factors associated with death and graft loss. DDLT and ABO incompatible transplant were prognostic factors for rejection, and HCC beyond Milan criteria at pre-transplant was a strong predictor of HCC recurrence. @*Conclusions@#This study is a good indicator of the post-LT prognosis in the Korean population and suggests a significant burden of post-LT complications.
RESUMO
BACKGROUND@#Prophylaxis for hepatitis B virus (HBV) recurrence is essential after liver transplantation (LT) in HBV-associated recipients. We conducted real-world analysis of HBV prophylaxis after LT in the Korean population.@*METHODS@#Korean Organ Transplantation Registry (KOTRY) database and additionally collected data (n = 326) were analyzed with special reference to types of HBV prophylaxis.@*RESULTS@#The study cohort comprised 267 cases of living-donor LT and 59 cases of deceased-donor LT. Hepatocellular carcinoma (HCC) was diagnosed in 232 (71.2%) of these subjects. Antiviral agents were used in 255 patients (78.2%) prior to LT. HBV DNA was undetectable in 69 cases (21.2%) and detectable over wide concentrations in the other 257 patients (78.8%) prior to LT. Polymerase chain reaction analysis of the store blood samples detected HBV DNA in all patients, with 159 patients (48.9%) showing concentrations > 100 IU/mL. Post-transplant HBV regimens during the first year included combination therapy in 196 (60.1%), hepatitis B immunoglobulin (HBIG) monotherapy in 121 (37.1%), and antiviral monotherapy in 9 (2.8%). In the second post-transplant year, these regimens had changed to combination therapy in 187 (57.4%), HBIG monotherapy in 112 (34.4%), and antiviral monotherapy in 27 (8.3%). Trough antibody to hepatitis B surface antigen titers > 500 IU/mL and >1,000 IU/mL were observed in 61.7% and 25.2%, respectively. The mean simulative half-life of HBIG was 21.6 ± 4.3 days with a median 17.7 days. Up to 2-year follow-up period, HCC recurrence and HBV recurrence developed in 18 (5.5%) and 6 (1.8%), respectively. HCC recurrence developed in 3 of 6 patients with HBV recurrence.@*CONCLUSION@#Combination therapy is the mainstay of HBV prophylaxis protocols in a majority of Korean LT centers, but HBIG was often administered excessively. Individualized optimization of HBIG treatments using SHL is necessary to adjust the HBIG infusion interval.
RESUMO
BACKGROUND@#Prophylaxis for hepatitis B virus (HBV) recurrence is essential after liver transplantation (LT) in HBV-associated recipients. We conducted real-world analysis of HBV prophylaxis after LT in the Korean population.@*METHODS@#Korean Organ Transplantation Registry (KOTRY) database and additionally collected data (n = 326) were analyzed with special reference to types of HBV prophylaxis.@*RESULTS@#The study cohort comprised 267 cases of living-donor LT and 59 cases of deceased-donor LT. Hepatocellular carcinoma (HCC) was diagnosed in 232 (71.2%) of these subjects. Antiviral agents were used in 255 patients (78.2%) prior to LT. HBV DNA was undetectable in 69 cases (21.2%) and detectable over wide concentrations in the other 257 patients (78.8%) prior to LT. Polymerase chain reaction analysis of the store blood samples detected HBV DNA in all patients, with 159 patients (48.9%) showing concentrations > 100 IU/mL. Post-transplant HBV regimens during the first year included combination therapy in 196 (60.1%), hepatitis B immunoglobulin (HBIG) monotherapy in 121 (37.1%), and antiviral monotherapy in 9 (2.8%). In the second post-transplant year, these regimens had changed to combination therapy in 187 (57.4%), HBIG monotherapy in 112 (34.4%), and antiviral monotherapy in 27 (8.3%). Trough antibody to hepatitis B surface antigen titers > 500 IU/mL and >1,000 IU/mL were observed in 61.7% and 25.2%, respectively. The mean simulative half-life of HBIG was 21.6 ± 4.3 days with a median 17.7 days. Up to 2-year follow-up period, HCC recurrence and HBV recurrence developed in 18 (5.5%) and 6 (1.8%), respectively. HCC recurrence developed in 3 of 6 patients with HBV recurrence.@*CONCLUSION@#Combination therapy is the mainstay of HBV prophylaxis protocols in a majority of Korean LT centers, but HBIG was often administered excessively. Individualized optimization of HBIG treatments using SHL is necessary to adjust the HBIG infusion interval.
RESUMO
BACKGROUND: Prophylaxis for hepatitis B virus (HBV) recurrence is essential after liver transplantation (LT) in HBV-associated recipients. We conducted real-world analysis of HBV prophylaxis after LT in the Korean population.METHODS: Korean Organ Transplantation Registry (KOTRY) database and additionally collected data (n = 326) were analyzed with special reference to types of HBV prophylaxis.RESULTS: The study cohort comprised 267 cases of living-donor LT and 59 cases of deceased-donor LT. Hepatocellular carcinoma (HCC) was diagnosed in 232 (71.2%) of these subjects. Antiviral agents were used in 255 patients (78.2%) prior to LT. HBV DNA was undetectable in 69 cases (21.2%) and detectable over wide concentrations in the other 257 patients (78.8%) prior to LT. Polymerase chain reaction analysis of the store blood samples detected HBV DNA in all patients, with 159 patients (48.9%) showing concentrations > 100 IU/mL. Post-transplant HBV regimens during the first year included combination therapy in 196 (60.1%), hepatitis B immunoglobulin (HBIG) monotherapy in 121 (37.1%), and antiviral monotherapy in 9 (2.8%). In the second post-transplant year, these regimens had changed to combination therapy in 187 (57.4%), HBIG monotherapy in 112 (34.4%), and antiviral monotherapy in 27 (8.3%). Trough antibody to hepatitis B surface antigen titers > 500 IU/mL and >1,000 IU/mL were observed in 61.7% and 25.2%, respectively. The mean simulative half-life of HBIG was 21.6 ± 4.3 days with a median 17.7 days. Up to 2-year follow-up period, HCC recurrence and HBV recurrence developed in 18 (5.5%) and 6 (1.8%), respectively. HCC recurrence developed in 3 of 6 patients with HBV recurrence.CONCLUSION: Combination therapy is the mainstay of HBV prophylaxis protocols in a majority of Korean LT centers, but HBIG was often administered excessively. Individualized optimization of HBIG treatments using SHL is necessary to adjust the HBIG infusion interval.
Assuntos
Humanos , Antivirais , Carcinoma Hepatocelular , Estudos de Coortes , DNA , Seguimentos , Meia-Vida , Antígenos de Superfície da Hepatite B , Vírus da Hepatite B , Hepatite B , Hepatite , Imunoglobulinas , Coreia (Geográfico) , Transplante de Fígado , Fígado , Transplante de Órgãos , Reação em Cadeia da Polimerase , Recidiva , TransplantesRESUMO
PURPOSE: Previous gastrectomy has been considered to be a relative contraindication for laparoscopic common bile duct exploration (LCBDE) because of concerns regarding severe adhesions in the operative field and technical complexity. This study evaluated the feasibility and safety of LCBDE in patients with previous gastrectomy. METHODS: We retrospectively reviewed the clinical outcomes of 58 patients who underwent LCBDE in our institution between January 2005 and December 2014: group I comprised patients with no previous abdominal surgery (n=43) and group II comprised patients with previous gastrectomy (n=15). Patient demographics and perioperative variables were compared between groups. RESULTS: The perioperative variables did not differ significantly between groups. The operating time, open conversion rate, and morbidity rate were similar in groups I and II, despite the more complicated cases in group II. Moreover, the presence of remnant bile duct stones and biliary strictures, and the postoperative hospital stay, did not differ significantly between groups. The mean time to oral intake did not differ between groups, although this diet resumption time was significantly shorter in groups I and II than in a group undergoing open choledocholithomy (p=0.04). CONCLUSION: Laparoscopic common bile duct exploration is safe and effective in patients with histories of gastrectomy.
Assuntos
Humanos , Ductos Biliares , Coledocolitíase , Ducto Colédoco , Constrição Patológica , Demografia , Dieta , Gastrectomia , Laparoscopia , Tempo de Internação , Estudos RetrospectivosRESUMO
Salvage living donor liver transplantation (LDLT) after major hepatectomy has been considered a challenging procedure due to operative complexity. We report a successful case of salvage dual graft LDLT after right hepatectomy. A 48-year-old male was transferred to Daegu Catholic University Medical Center because of duodenal variceal bleeding. He underwent right hepatectomy due to hepatocellular carcinoma four years prior. We performed LDLT with dual graft from his wife and sister. During operation, portal vein anastomosis of the right lobe graft was performed using an interposing cadaveric iliac vein graft and the right gastroepiploic artery was anastomosed to the hepatic artery of the left lobe graft. Adequate graft inflow was demonstrated by postoperative imaging studies. He has been doing well with normal graft function for 31 months. Salvage dual graft LDLT could be undertaken successfully in patients with prior major hepatectomy under accurate preoperative planning and proper surgical techniques.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Centros Médicos Acadêmicos , Cadáver , Carcinoma Hepatocelular , Varizes Esofágicas e Gástricas , Artéria Gastroepiploica , Hepatectomia , Artéria Hepática , Veia Ilíaca , Transplante de Fígado , Doadores Vivos , Veia Porta , Terapia de Salvação , Irmãos , Cônjuges , TransplantesRESUMO
Despite a remarkable increase of deceased donors, organ shortage is the main hurdle of organ transplantation in Korea. Therefore, liver transplantation priority is a major issue of liver allocation. We confront a situation that needs to change in order to achieve more adequate and objective allocation of the system. We considered the MELD system as an alternative to the CTP score and Status system. For application of the MELD system, comparison between two systems is required; and a national-based retrospective review of liver transplantation candidates (waiting list) was conducted as a multi-center collaborative study. Eleven transplant centers participated in this national study. From 2009 to 2012, 2,702 waiting lists were enrolled. After mean 349+/-412 days follow-up, 967 patients (35.8%) of liver transplantation, 750 patients (27.8%) of drop-out/mortality, and 719 patients (26.6%) on waiting were identified. In analysis of patient mortality during waiting time, status system showed significant difference of waiting mortality by status at registration. However, differences of waiting mortality by MELD system were more prominent and discriminate. In comparisons by MELD score in exclusive Status 2A waiting patients, there was a significant difference of waiting mortality by MELD score. This means that the MELD system is a good predictor of short-term survival after listing compared with status system with CTP score. Korean national-based retrospective study showed the superiority of the MELD system in prediction of short-term mortality and usefulness as a determinant for allocation priority.
Assuntos
Humanos , Citidina Trifosfato , Emergências , Doença Hepática Terminal , Seguimentos , Coreia (Geográfico) , Transplante de Fígado , Fígado , Mortalidade , Transplante de Órgãos , Alocação de Recursos , Estudos Retrospectivos , Análise de Sobrevida , Doadores de Tecidos , Transplantes , Listas de EsperaRESUMO
Extensive thrombosis of the portal and splenomesenteric veins combined with cavernous transformation of the portal vein (CTPV) has been considered to be a contraindication for living donor liver transplantation (LDLT) due to technical difficulties and perioperative risks. In recent years, several surgical innovations including cavoportal hemitransposition, renoportal anastomosis, and portal arterialization have been introduced to overcome diffuse portal vein thrombosis (PVT) and CTPV, but their outcomes were unsatisfactory with significant morbidity and mortality. Herein, we report two successful cases of adult LDLT in diffuse PVT with CTPV managed using the paracholedochal vein as portal inflow to the graft.
Assuntos
Adulto , Humanos , Transplante de Fígado , Doadores Vivos , Mortalidade , Veia Porta , Trombose , Transplantes , Veias , Trombose VenosaRESUMO
PURPOSE: Groove pancreatitis is a rare specific form of chronic pancreatitis that extends into the anatomical area between the pancreatic head, the duodenum, and the common bile duct, which are referred to as the groove areas. We present the diagnostic modalities, pathological features and clinical outcomes of a series of symptomatic patients with groove pancreatitis who underwent pancreaticoduodenectomy. METHODS: Six patients undergoing pancreaticoduodenectomy between May 2006 and May 2009 due to a clinical diagnosis of symptomatic groove pancreatitis were retrospectively included in the study. RESULTS: Five cases were male and one case was female, with a median age at diagnosis of 50 years. Their chief complaints were abdominal pain and vomiting. Abdominal computed tomography, endoscopic ultrasound and endoscopic retrograde cholangiopancreatography were performed. Preoperative diagnosis of all patients was groove pancreatitis. Histological finding was compatible with clinically diagnosed groove pancreatitis in five patients and the pathologic diagnosis of the remaining patient was adenocarcinoma of distal common bile duct. Following pancreaticoduodenectomy, four living patients experienced significant pain alleviation. CONCLUSION: The diagnostic imaging modalities of choice for groove pancreatitis are computed tomography and endoscopic ultrasonography. If symptomatic groove pancreatitis is suspected, careful follow-up of patients is necessary and pancreaticoduodenectomy seems to be a reasonable treatment option.
Assuntos
Feminino , Humanos , Masculino , Dor Abdominal , Adenocarcinoma , Colangiopancreatografia Retrógrada Endoscópica , Doença Crônica , Ducto Colédoco , Diagnóstico por Imagem , Duodeno , Endossonografia , Cabeça , Neoplasias Pancreáticas , Pancreaticoduodenectomia , Pancreatite , Pancreatite Crônica , Estudos Retrospectivos , VômitoRESUMO
PURPOSE: Portal vein thrombosis (PVT) has been considered a relative contraindication for living donor liver transplantation (LDLT). However, it is no longer a contraindication of LDLT due to improvement in surgical techniques and approaches to PVT. The aim of this study was to assess the impact of PVT on outcomes in LDLT patients. METHODS: We retrospectively analyzed the data from 97 adult patients undergoing LDLT in our center from July 2008 to June 2010. Intraoperative findings and preoperative imaging results were reviewed for PVT grading (Yerdel grading). We analyzed the technical aspects and comparisons of risk factors, perioperative variables, and survivals between patients with and without PVT based on the grades. RESULTS: In the 97 LDLT patients, 18 patients were confirmed to have PVT (18.5%) including grade I cases (n = 8), grade II (n = 7), and grade III (n = 3). Prior treatment of portal hypertension was found to be an independent risk factor for PVT (P = 0.001). The comparisons between PVT and no PVT groups showed no significant difference in intraoperative and postoperative variables except for postoperative bleeding (P = 0.036). The short-term portal vein patency, in-hospital mortality and survival rates were not significantly different between the PVT and control groups. CONCLUSION: The outcomes are similar to non-PVT group in terms of in-hospital mortality, survival rates, and postoperative complications. Therefore, our study suggests that PVT cannot be considered to be a contraindication for LDLT and LDLT could be undertaken without increased morbidity and mortality in patients with PVT, in spite of operative complexity.
Assuntos
Adulto , Humanos , Hemorragia , Mortalidade Hospitalar , Hipertensão Portal , Fígado , Transplante de Fígado , Doadores Vivos , Veia Porta , Complicações Pós-Operatórias , Estudos Retrospectivos , Fatores de Risco , Taxa de Sobrevida , TromboseRESUMO
End-stage liver disease is often accompanied by portal vein thrombosis (PVT) and large spontaneous splenorenal shunts (SRS). Recently, renoportal anastomosis (RP-A) of spontaneous splenorenal shunts in liver transplantation was reported as an effective method of portal vein reconstruction in cases of PVT with SRS. Here we report a successful case of RP-A in living donor liver transplantation (LDLT). A 46-year-old female with a large spontaneous splenorenal shunt and a portal vein thrombosis propagated to the superior mesenteric vein underwent living donor liver transplantation. At the operation, a side-to-end renoportal anastomosis was done using an interposing cadaveric iliac vein graft. Adequate portal venous blood flow was demonstrated by intraoperative and postoperative Doppler ultrasound studies. She has recovered well with normal graft function and renal function. Renoportal anastomosis for patients with large splenorenal shunts and expansive portal vein thrombosis to the superior mesenteric vein can be an effective and safe technique in patients PV thrombectomy.
Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Cadáver , Veia Ilíaca , Fígado , Hepatopatias , Transplante de Fígado , Doadores Vivos , Veias Mesentéricas , Veia Porta , Derivação Esplenorrenal Cirúrgica , Trombectomia , Trombose , TransplantesRESUMO
BACKGROUND: In living-donor-liver transplantation, microsurgical reconstruction of the hepatic artery is essential and this is challenging issue because of the small diameter of the vessels in the partial liver graft. We present our experiences for hepatic arterial reconstruction with focusing on the technical aspects. METHODS: Methods: From May 2005 through December 2009, 100 patients received right hemiliver grafts (n=86) or left hemiliver grafts (n=14). Hepatic artery anastomosis was performed using microsurgical techniques. All the anastomoses were successfully accomplished by a single transplantation surgeon who worked under a microscope. Our classical method for arterial reconstruction in living donor liver transplantation (LDLT) consists of the interrupted end-to-end anastomosis between the hepatic artery of the graft and the most accessible hepatic artery of the recipient. RESULTS: We could confirm the patency of the reconstructed artery during the early post-transplantation period. Ninety five patients had the hepatic arteries reconstructed by the conventional twist technique. We used the right gastroepiploic artery in one patient because of the intimal dissection of the hepatic artery, and we used an interposition graft, with using the greater saphenous vein, in 2 patients. technical complication was occurred in only 1 patient. The hepatic artery pseudoaneurysm was confirmed at 4 weeks after transplantation. Arterial steal syndrome was detected in 2 patients and this was treated by angiographic techniques. CONCLUSIONS: Meticulous intraoperative microsurgical techniques and careful postoperative evaluation are very important in the hepatic artery reconstruction of LDLT. An experienced transplantation microscopy surgeon is also needed for creating safe anastomosis and achieving a lower complication rate.
Assuntos
Humanos , Falso Aneurisma , Artérias , Artéria Gastroepiploica , Artéria Hepática , Fígado , Transplante de Fígado , Doadores Vivos , Microscopia , Microcirurgia , Procedimentos de Cirurgia Plástica , Veia Safena , Trombose , TransplantesRESUMO
Securing the source of hepatic artery inflow is essential for living donor liver transplantation. However, sometimes, the hepatic arteries of the recipients are in poor condition for a good anastomosis in living donor liver transplantation; problems include severe arteriosclerosis, intimal dissection, and significant intimal injuries caused by previous transarterial procedures. In these conditions, the right gastroepiploic artery has generally been the preferred artery because of its anatomical location, size and length. Here, a case of successful hepatic artery reconstruction is reported using the right gastroepiploic artery in living donor liver transplantation. The recipient's hepatic arterial intima was severely injured by multiple transarterial chemoembolization and unsuitable for reconstruction. Instead, the right gastroepiploic artery was anastomosed to the hepatic artery of the graft. Arterial blood flow was satisfactory on Doppler ultrasonography during the operation, and complications related to the hepatic artery were not detected during the follow-up period. Therefore, the right gastroepiploic artery may be considered as a suitable alternative for hepatic artery reconstruction in living donor liver transplantation.
Assuntos
Humanos , Artérias , Arteriosclerose , Seguimentos , Artéria Gastroepiploica , Artéria Hepática , Fígado , Transplante de Fígado , Doadores Vivos , Transplantes , Túnica Íntima , Ultrassonografia DopplerRESUMO
We present a 45-year-old man with chronic pancreatitis and the rare complication of large subcapsular splenic pseudocyst. He suffered from a slow growing left upper quadrant abdominal distension for 2 weeks and pain radiating to his back. On abdominal computed tomography, large subcapsular splenic pseudocyst (25x13x11 cm), multiple small sized pancreatic pseudocysts in the pancreas tail and chronic pancreatitis with multiple pancreatic stones were shown. He underwent percutaneous catheter drainage of the splenic pseudocyst and after 3 weeks, the size of the pseudocyst decreased. But, the pain radiating to his back and poor oral intake was not improved. Distal pancreatectomy, Roux-en-Y pancreaticojejunostomy, and splenectomy were performed and the patient was discharged after 2 weeks. A splenic subcapsular pseudocyst resulting from pancreatitis may be managed by percutaneous drainage, but according to a patient's clinical symptoms, operative management can be added.
Assuntos
Humanos , Pessoa de Meia-Idade , Catéteres , Drenagem , Pâncreas , Pancreatectomia , Pseudocisto Pancreático , Pancreaticojejunostomia , Pancreatite , Pancreatite Crônica , Baço , EsplenectomiaRESUMO
Necrotizing fasciitis is a rapidly spreading subcutaneous infection. It can occur in patients after solid organ transplantation. But, the reports for necrotizing fasciitis after liver transplantation are very unusual. We report 2 patients with necrotizing fasciitis caused by bacterial and Aspergillus species infection. Their pre-transplantation condition was very poor due to hepatic encephalopathy, pressure sore, and admission for several months. Patients had a fulminant course for early potent immunosuppression period, despite of aggressive surgical debridement, withdrawal of immunosuppression, and adequate antibacterial and antifungal therapy. Therefore, necrotizing fasciitis has to be recognized as a potential complication after liver transplantation and Aspergillus species has to be added to the list of potential pathogens of surgical wound infections, especially in the setting of liver transplantation.
Assuntos
Humanos , Aspergillus , Desbridamento , Fasciite , Fasciite Necrosante , Encefalopatia Hepática , Terapia de Imunossupressão , Fígado , Transplante de Fígado , Necrose , Transplante de Órgãos , Úlcera por Pressão , Infecção da Ferida Cirúrgica , TransplantesRESUMO
PURPOSE: The increasing number of recipients on the waiting list for orthotopic liver transplantation (OLT) and the scarcity of donors contribute to recipient's pre-transplantation mortality. So, the expansion of donor criteria has become necessary with the increasing number of liver transplantation candidates, as aged donors who have been considered to yield marginal organs. METHODS: We retrospectively analyzed the 18 deceased donor liver transplantations which had been performed between November 2004 and December 2007. Nine patients received liver grafts from donors older than 50 years, the other 9 patients from donors younger than 40 years. Pre- transplantation characteristics of donors and the early graft outcomes of recipients were evaluated. RESULTS: The pre- transplantation status of the patients who received the older and younger grafts was similar, except donor age. Graft function - as determined by peak aminotransferase levels, prothrombin time (INR) and total bilirubin level after transplantation - was not significantly different in older versus younger grafts. Length of ICU stay and hospital stay of recipients were not influenced from donor's pre-transplant status and cold ischemic time. Fatty changes on frozen section biopsy was related with length of recipient's ICU stay (P=0.049), but all enrolled donors had mild macrovesicular fatty changes (<30%) and fatty changes had no relationship with early graft function and total length of recipient's hospital stay. CONCLUSION: Fifty to sixty-five years brain-dead donors could be transplanted with the same initial success as younger livers provided that other generally accepted donor criteria are satisfactory and the cold ischemic time is short. Further studies should be performed for long-term results and we must make effort to find donors older than 65 years.
Assuntos
Idoso , Humanos , Fatores Etários , Bilirrubina , Biópsia , Isquemia Fria , Secções Congeladas , Tempo de Internação , Fígado , Transplante de Fígado , Tempo de Protrombina , Estudos Retrospectivos , Doadores de Tecidos , Transplantes , Listas de EsperaRESUMO
The liver is a common site for carcinoid metastases, and primary hepatic carcinoid tumor (PHCT) is a very rare entity. The diagnosis of PHCT is principally based on the histopathological confirmation of carcinoid tumor and the exclusion of a nonhepatic primary tumor. A 45-year-old man who presented with an intraabdominal abscess caused by recurrent peptic ulcer perforation had a huge heterogeneous mass in the central portion of the liver. The preoperative impression was peripheral cholangiocellular carcinoma. Central bisectionectomy was performed together with difficult adhesiolysis. On surgical exploration, there were no extrahepatic lesions. The postoperative course was uneventful, except for biloma formation, and the pathologic biopsy result was carcinoid tumor with positive immunohistochemical staining for chromogranin A. Our patient has been free of symptoms, including peptic ulcer, and there have been no abnormal findings on the follow-up abdominal images for 1 year. Accordingly, the diagnosis was primary hepatic carcinoid. In conclusion, PHCT should be diagnosed by the absence of extrahepatic lesion on surgical exploration and follow up throughout the clinical and imaging studies. A preoperative suspicion of PHCT is significant for conducting clinical investigations of a tumor's characteristics.
Assuntos
Humanos , Pessoa de Meia-Idade , Abscesso , Biópsia , Tumor Carcinoide , Colangiocarcinoma , Cromogranina A , Seguimentos , Fígado , Metástase Neoplásica , Úlcera Péptica , Úlcera Péptica PerfuradaRESUMO
Adenosquamous carcinoma of the pancreas is a rare tumor that has a less than favorable prognosis because of its aggressive biological behavior. A 47-year-old man was admitted with complaints of right upper quadrant pain of the abdomen. Abdominal computed tomography (CT) demonstrated a low density solid mass lesion in the uncinate process of the pancreas. Dynamic CT, fine needle aspiration by endoscopic ultrasound and the cytological examination by endoscopic retrograde cholangiopancreatography were performed for making the preoperative diagnosis, but the results were a disappointment. Pylorus preserving pancreatoduodenectomy was performed. The resection specimen was composed of squamous cell carcinoma components mixed with adenocarcinoma. The patient stopped further treatment after his 1st chemotherapy cycle because of his poor condition, which due to multiple metastases to the liver and lymph nodes. We report here on a case of adenosquamous carcinoma of the pancreas and we review the relevant Korean literature.
Assuntos
Humanos , Pessoa de Meia-Idade , Abdome , Adenocarcinoma , Biópsia por Agulha Fina , Carcinoma Adenoescamoso , Carcinoma de Células Escamosas , Colangiopancreatografia Retrógrada Endoscópica , Fígado , Linfonodos , Metástase Neoplásica , Pâncreas , Pancreaticoduodenectomia , Prognóstico , PiloroRESUMO
Placement of a pulmonary artery catheter for hemodynamic monitoring in the operating room or intensive care unit is very useful, but this is associated with various complications. They are rupture of the pulmonary artery, pneumothorax, hemothorax, thromboembolism, hemoptysis, arrythmia, valvular damage, sepsis, rupture of the balloon, entrapment or knotting of the catheter and so on. We experienced a case of perforation of the superior vena cava that was caused by a pulmonary artery catheter during liver transplantation. We diagnosed hemothorax during the operation, and we recognized the perforation by performing thoracoscopy. The perforation site was sutured successfully and there were no more problems.